ArticleInvestigative ophthalmology & visual science2024
Sequence and Detectability of Changes in Macular Ganglion Cell Layer Thickness and Perfusion Density in Early Glaucoma.
Article in Investigative ophthalmology & visual science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate whether macular perfusion density (PD) changes measured over time by optical coherence tomography angiography (OCTA) are detectable before progressive macular ganglion cell layer (GCL) thinning in early glaucoma. Methods: This prospective longitudinal cohort study involved patients with early open-angle glaucoma and healthy subjects imaged by OCT and OCTA every 4 months. GCL thickness and macular PD were evaluated in 16 tiles in the macula. We estimated baseline percentage losses of GCL thickness or macular PD in glaucoma patients with age-corrected normative values derived from the healthy subjects. Additionally, the threshold slope separating glaucoma patients from healthy subjects with 90% specificity was used to determine the number of patients with steeper slopes than the threshold slope. Results: Eighty patients with glaucoma and 42 healthy subjects were included. In eight tiles (50%), patients with a significant macular PD slope had a significantly greater baseline percentage loss of GCL thickness relative to macular PD compared to patients without a significant macular PD slope. Furthermore, in 15 tiles (94%), a greater baseline percentage loss of GCL thickness relative to PD was significantly correlated with faster PD slopes. In contrast, only one tile (6%) showed these significant trends for GCL slopes. The number of patients with faster GCL slopes than threshold slopes was significantly larger than patients with faster PD slopes in 12 tiles (75%). Conclusions: A decrease in GCL thickness precedes a measurable decrease in macular PD. Early glaucomatous progression is more frequently detectable with changes in GCL thickness compared to macular PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.